Abstract From time to time, paediatricians are confronted with children who might suer from a primary immunode®ciency disease. For practical purposes, these children can be divided into four main clinical categories: (1) a relatively large group of children with recurrent ear-nose and throat and lower respiratory tract infections, in some cases caused by de®ciencies of antibodies or complement; (2) children with failure to thrive, intractable diarrhoea or an opportunistic infection which can be caused by a T-lymphocyte or combined immunode®ciency; (3) children with infections with pyogenic bacteria or fungi as seen in case of granulocyte/ monocyte function de®ciency; and (4) a small heterogeneous group of children with recurrence of particular infections. Also, acquired immunode®ciency becomes a more common problem in paediatric practice. Flow cytometric immunophenotyping of leucocytes appears to be an ecient and rapid tool in the diagnosis and followup of immunode®cient patients, supporting early recognition, before serious infections have compromised the child's general condition. This technique can now be performed in many hospitals. In this review, we give directions for the use of¯ow cytometric immunophenotyping of leucocytes in the diagnosis and follow-up of immunode®cient children according to the four main clinical categories.
Introduction
From time to time, paediatricians are confronted with children who might suer from a primary immunode®ciency disease [21] . For practical purposes, these children can be divided into four main clinical categories [7, 26, 28] . The ®rst clinical category comprises the relatively large group of children with recurrent ear-nose and throat (ENT) and lower respiratory tract infections, only in some cases caused by an underlying immunode®ciency, especially if encapsulated extracellular bacteria are found as pathogens. In patients with hypo-or agammaglobulinaemia, de®cient opsonisation with antibodies leads to impaired phagocytosis of these micro-organisms. Complement de®ciencies are rare and in most types of complement de®ciency aected children present with collagen-vascular disease [15] . However, some complement de®ciencies lead to severely impaired opsonisation with recurrent serious bacterial infections resembling agammaglobulinaemia (C3 de®-ciency, factor D de®ciency and factor I de®ciency; to a lesser extent C2 de®ciency). Most children with recurrent, often viral, ENT and lower respiratory tractde®ciency, but are immunocompetent. Their problems are due to other more common causes such as bronchial hyperreactivity, adenoidal hypertrophy, or an allergic constitution, or they may suer from rare non-immunological diseases like cystic ®brosis or immotile cilia syndrome.
The second clinical category comprises children with failure to thrive, intractable diarrhoea or an opportunistic infection, which can be caused by a T-lymphocyte or combined immunode®ciency with absent or functionally de®cient T-lymphocytes. Their defence against intracellular micro-organisms is inadequate. The third clinical category comprises children with super®cial and systemic infections with pyogenic bacteria or fungi, who apparently have problems with their ®rst line of defence against invading micro-organisms as in cases of granulocyte/monocyte function de®ciency. Finally, the fourth clinical category comprises a small heterogeneous group of children with recurrence of particular infections such as recurrent neisserial infections in cases of late complement component de®ciency, or recurrent mycobacterial infections in cases with a defect in the interferon (IFN)-c receptor, interleukin (IL)-12 or the IL-12 receptor [19] . These last three clinical categories are only rarely encountered in general paediatric practice.
Most cases of acquired immunode®ciency are iatrogenic and can therefore be anticipated: as more and more children are being treated with immunosuppressive drugs, aggressive chemotherapy protocols, and stem cell transplantation, acquired immunode®ciency becomes a more common problem in paediatric practice [4] . Also, the prevalence of paediatric human immunode®ciency virus (HIV) infection in Europe is increasing, especially in children born to parents who originate from HIVendemic areas [8] .
Laboratory studies for identi®cation and clinical follow-up of immunode®cient children can now be performed in many hospitals. In this review, we focus our discussion on the increasingly important role of¯ow cytometric immunophenotyping of leucocytes in the diagnosis and follow-up of immunocompromised children in paediatric practice [12] . Application of¯ow cytometric techniques helps to speed up the diagnostic process, thereby supporting early recognition of primary immunode®ciencies before serious infections have compromised the child's general condition, reducing the chances of survival [21] .
Flow cytometric immunophenotyping
Flow cytometric immunophenotyping allows precise assessment of relative frequencies of leucocyte subpopulations by detection of cell surface and intracellular markers with¯uorochrome-labelled monoclonal antibodies (McAb). Immunophenotyping can be focussed on lymphocytes, monocytes, or granulocytes, because these leucocyte populations can be de®ned on the basis of their light scatter characteristics, such as forward scatter (FSC) as measure for size, and side scatter (SSC) as measure for cellular irregularity (Fig. 1) [12] . Leucocyte count and dierential cell count can then be used to calculate absolute counts of the blood lymphocyte subpopulations, which should be compared with agematched reference values [6] .
Blood sample handling, cell separation methodology and labelling techniques in¯uence the reliability of the results obtained by¯ow cytometric immunophenotyping of leucocytes [12] . Dead cells show increased auto¯uorescence, potentially leading to incorrect interpretation of staining results. This can be minimised by using freshly collected samples which are fully analysed within 24 h. The immunophenotyping procedures take 4±5 h, implying that the sample should arrive in the laboratory in the morning. Cell separation via density gradients may result in dierential loss of speci®c lymphocyte subpopulations. This is avoided when the lysed whole blood (LWB) technique is used. The currently available LWB techniques require fewer preparation steps and less sample handling via direct incubation of the anticoagulated blood with McAbs, in combination with red blood cell lysis. These LWB techniques also reduce non-speci®c binding of McAbs, especially if the applied McAbs are directly conjugated with¯uoro-chromes. 
Diagnosing children with primary immunode®ciency
Children with recurrent ENT and lower respiratory tract infections
In some children with recurrent ENT and lower respiratory tract infections, a relatively mild antibody de®-ciency like IgA de®ciency, IgG subclass de®ciency, or anti-polysaccharide antibody de®ciency is found [21] . Lymphocyte number and immunophenotype are completely normal in these children (Table 1) . It is useful to perform immunophenotyping of lymphocytes according to the``limited'' protocol (Table 2 ), when a rare severe antibody de®ciency with hypo-or agammaglobulinaemia is found. Determination of Tlymphocyte counts generally rules out severe combined immunode®ciency (SCID) and determination of B-lymphocyte counts supports the discrimination between the various causes of severe antibody de®ciency (Table 1 ) [21] . If immunophenotyping of lymphocytes shows that B-lymphocytes are virtually absent in the peripheral blood compartment (Fig.1) , this strongly suggests an early stop in B-lymphocyte development. This occurs in X-linked agammaglobulinaemia with Bruton tyrosine kinase (BTK) de®ciency as well as in rare autosomal recessive forms of agammaglobulinaemia, such as Igl heavy chain de®ciency. Using a McAb directed against BTK, it is now possible to detect BTK de®ciency in most patients by analysing the monocytes with¯ow cytometry; normal monocytes also express BTK [14] . Furthermore, the type of B-cell dierentiation arrest in bone marrow can be assessed with a special research protocol ( Fig. 2) and can direct the diagnostic analysis at the molecular level (Fig. 3) .
If B-lymphocytes are present in the peripheral blood compartment of patients with a severe antibody de®-ciency, common variable immunode®ciency or hyperIgM syndrome are more likely diagnoses. In common variable immunode®ciency, progressive hypogammaglobulinaemia with combinations of IgA de®ciency, IgG subclass de®ciency, and/or anti-polysaccharide antibody de®ciency can be found. Immunophenotyping of blood lymphocytes can show accompanying T-lymphocytopenia [25] . In X-linked hyper-IgM syndrome with a defect in CD40 ligand (CD40L), severe hypogammaglobulinaemia with normal or increased IgM is found. Immunophenotyping of activated blood T-lymphocytes can show absence or decreased expression of CD40L (Fig. 4 ) ( Table 2 ) [16] . In some patients CD40L is expressed but not functional; tests for CD40 binding can identify these patients. The defect in CD40L disrupts the CD40L-CD40 mediated T-B cell communication, which is indispensable for isotype switching from IgM to IgG, IgA or IgE. Consequently, X-linked hyper-IgM syndrome is not a pure antibody de®ciency but should be considered as a T-lymphocyte disorder, which probably explains why aected children often present with an opportunistic infection. The de®nitive diagnosis of X-linked hyper-IgM syndrome can be made via mutation analysis of the CD40L gene. The autosomal recessive form of hyper-IgM syndrome is caused by mutations in the activation-induced cytidine deaminase (AID) gene. AID proteins are speci®cally expressed in germinal centre Bcells in secondary lymphoid organs and are required for immunoglobulin isotype switching as well [23] .
Children with failure to thrive, intractable diarrhoea, or with an opportunistic infection Many children with T-lymphocyte or combined immunode®ciency do not present with recurrent infections but with failure to thrive or intractable diarrhoea [26] . The dierential diagnosis is extensive in these cases. The combination of lymphopenia and agammaglobulinaemia can direct the search towards an immunode®cien-cy, but these are not invariably present. Opportunistic infections almost always indicate an immunode®ciency, either acquired (see below) or congenital.
The``limited'' immunophenotyping protocol as shown in Table 2 can easily detect severe combined immunode®ciency disease. Generally, T-lymphocytes will be absent or very low in number [21] . However, transplacental transfer of maternal T-lymphocytes in SCID patients or remaining (oligoclonal) T-lymphocyte production in Omenn syndrome (Table 1 ) might coincidentally lead to seemingly normal T-lymphocyte counts. The presence or absence of B-lymphocytes differentiates between B + SCID and B -SCID, as found in X-linked common c-chain de®ciency or autosomal recessive Janus-associated kinase-3 (JAK3) de®ciency and in recombination activating genes (RAG)-1 or -2 de®-ciency, respectively (Fig. 5 ). Major changes in either the CD4 + /CD3 + helper T-lymphocyte count or the CD8 + / CD3 + suppressor/cytotoxic T-lymphocyte count can be suggestive for the diagnosis of MHC class II de®ciency with low CD4 + /CD3 + counts [5] or a diagnosis of 70 kD zeta-associated protein (ZAP70) tyrosine kinase de®ciency with low CD8 + /CD3 + counts, respectively ( Fig. 3) (Table 1 ). However, in many cases of combined immunode®ciency, immunophenotyping results are less aberrant with lymphopenia developing over time. Additional tests are then required to obtain a diagnosis. Lymphopenia develops within months after birth in adenosine deaminase or purine nucleotide phosphorylase de®ciency due to metabolic poisoning of the cells. Lymphopenia also gradually develops in the ®rst years after birth in Wiskott-Aldrich syndrome and towards adolescence or even adulthood in ataxia teleangiectasia (Table 1 ) [10] .
If immunode®ciency is highly suspected but thè`l imited'' immunophenotyping protocol shows no abnormalities, an``extended'' immunophenotyping protocol as shown in Table 2 can identify additional children with speci®c subtypes of T-lymphocyte or combined immunode®ciency that are not accompanied by major changes in the main lymphocyte populations (Table 1) . [12, 13, 21] . These protocols may include markers of maturation, such as CD45RA (``naive'') and CD45RO (``memory'') on Tlymphocytes, markers of activation and/or proliferation, co-stimulatory and/or signalling molecules, and intracellular cytokines, such as IL2 and IFN-c (T-helper 1 pro®le), and IL4, IL5, and IL10 (T-helper 2 pro®le). These tests are generally not performed in routine laboratories and will not be further discussed here.
Children with super®cial and systemic infections with pyogenic bacteria or fungi Most children with super®cial and systemic infections with pyogenic bacteria or fungi suer from neutropenia due to haematological disorders or iatrogenic causes (see below). Flow cytometric immunophenotyping of leuco- Table 2 ) [3] . In leucocyte adhesion de®ciency type 1 (CD18 de®ciency) and type 2 (CD15s de®ciency), leucocyte adhesion is impaired. This leads to leucocytosis, which is even more pronounced during infections [21] . CD18 and CD15s expression can be analysed with immunophenotyping (Table 2 ) (Fig. 6 ) [1, 11] .
Children with recurrent particular infections De®ciencies in one of the components of the terminal complement pathway result in recurrent neisserial, mainly meningococcal, infections (C6 de®ciency, C7 de®ciency, C8 de®ciency, and C9 de®ciency; also properdin de®ciency) [15] . Lymphocyte number and immunophenotype are normal in these children (Table 1) . De®ciencies in the IFN-c receptor, IL-12 or the IL-12 receptor lead to recurrent mycobacterial infections [19] . The IL-12 receptor can be detected on T-lymphocytes or NK-cells and the IFN-c receptor can be detected on monocytes by¯ow cytometry. Information about the expression patterns of these molecules can direct the diagnostic analysis at the molecular level, but it is im- The``lymphosum'' should equal 92%±98% (=% T+% B+% NK)`E xtended'' protocol (performed in specialised laboratories only; select relevant items based on the information presented in Table 1 ; always perform the``limited'' protocol as well; compare with normal age-matched controls run in parallel, if no reference values are available) Analysis of the arrest in B-cell development in the bone marrow and of the intracellular expression of BTK in monocytes of patients with agammaglobulinaemia with absent B-lymphocytes Common c-chain expression (CD132) on lymphocytes in SCID patients with B-lymphocytes CD40L expression (CD154) on activated T-lymphocytes in hypogammaglobulinaemia with normal or high IgM; CD40L function is assessed by CD40 binding assays HLA-DR (class-II) and b 2 microglobulin (class I) expression on leucocytes in children suspected of severe combined immunode®ciency with normal lymphocyte numbers and phenotype on initial screening TCRab-and TCRcd-expression on T-lymphocytes in children with neonatal hypocalcaemia and congenital heart disease Extensive specialised protocols in unclassi®able cases of combined immunode®ciency with stainings for`naive' (CD45RA) and`memory' (CD45RO) T-lymphocytes, for markers of activation and proliferation, for co-stimulatory and signalling molecules, and for intracellular cytokines (T-helper 1 and T-helper 2 pro®les) Intracellular cytochrome b558 expression in phagocytes if chronic granulomatous disease is suspected in children with phagocyte function de®ciency CD18 and CD15s expression on leucocytes if leucocyte adhesion de®ciency type 1 or type 2 is suspected in children with phagocyte function de®ciency and extreme leucocytosis Analysis of the IL-12 receptor b1 chain on T-lymphocytes/NK cells and of intracellular IL-12 and the IFN-c receptor chains on monocytes in children with recurrent mycobacterial infections portant to realise that protein expression does not necessarily imply intact protein function.
Follow-up of children with acquired immunode®ciency
During follow-up of children treated with immunosuppressive drugs or chemotherapy, the degree of neutropenia is easily assessed with a leucocyte count and dierential. The slow reconstitution of lymphocytes after bone marrow transplantation [2] can be monitored by a simple immunophenotyping protocol to determine the numbers of the main lymphocyte populations (``limited'' protocol in Table 2 ). It should be kept in mind, however, that functional restoration of the lymphoid system takes more time than is needed for the normalisation of absolute counts [22] . HIV infection is generally diagnosed by serology or polymerase chain reaction. Immunophenotyping has a role in the follow-up of HIV-infected children with the determination of decreasing CD4 + /CD3 + helper Tlymphocyte counts as a prognostic marker for the development of AIDS: long-term risk of mortality increases from 33% to 97% with baseline CD4 + percentage decreasing from ³35% to <5% [18] . It also has a role, together with HIV RNA quanti®cation, for the timing of antiretroviral therapy. The CD4 + helper T-lymphocyte count is used for the classi®cation of the degree of immune suppression: ³1500/ll under 12 months of age, ³1000/ll from 1±5 years of age, and ³500/ll from 6±12 years of age indicate the absence of immune suppression, whereas <750/ll under 12 months of age, <500/ll from 1±5 years of age, and <200/ll from 6±12 years of age indicate severe suppression [27] . During antiretroviral therapy, monitoring of CD4 + helper T-lymphocyte counts is useful for evaluating the treatment eectiveness [20] in addition to HIV RNA quanti®cation [27] . For further guidelines, the reader is referred to the literature [27] .
More elaborate immunophenotyping protocols can be reserved for research purposes, e.g. for comparison of immune reconstitution after bone marrow transplantation with normal ontogeny. Such studies are important for understanding the regeneration processes, but have no direct clinical relevance as yet.
Conclusion
Immunophenotyping of leucocytes forms an important part of the diagnostic work-up in children with suspected immunode®ciency. A``limited'' protocol (Table  2 ) can be performed in many hospitals. This enables the general paediatrician to determine the presence and number of the main lymphocyte populations to identify (severe) combined immunode®ciency patients at an early stage and to direct the diagnostic work-up in agammaglobulinaemic patients by determining the presence or absence of B-lymphocytes. In selected cases, a set of extra measurements can be performed in specialised laboratories (``extended'' protocol in Table 2 ). This identi®es children with immunode®ciencies that are not accompanied by major changes in the main lymphocyte populations. However, it should be noted that not all children with an immunode®ciency show alterations in immunophenotyping results (Table 1) . Also, genetic mutations do not always lead to absence of protein expression, even if protein function is severely hampered.
More extensive immunophenotyping protocols used in specialised laboratories or research settings help to recognise new immunode®ciency diseases by identifying as yet undescribed staining patterns. Also, pathogenesis of known defects can be further elucidated: the absence of speci®c cell surface markers [16, 21] , the loss of speci®c epitopes de®ned by McAb staining patterns [9, 17] , or the determination of the B-cell dierentiation arrest in bone marrow can support the precise characterisation of the defect. Therefore, it is important to use these more extensive immunophenotyping protocols in patients with an established immunode®ciency disease, as well as in patients with probable immunode®ciency disease that has not been proven with other methods.
Due to the rapid developments in the ®eld of¯ow cytometry and antibody production on the one hand and the recognition of new immunode®ciency diseases on the other, it is likely that the``limited'' and``extended'' immunophenotyping protocols de®ned here will need to be updated in a few years time. SCID patient with a mutation in the RAG2 gene. This girl presented at the age of 12 months with recurrent otitis media and respiratory infections, and chronic diarrhoea. Dot plot with FSC and SSC shows the``lympho-gate'' (left). Within the``lymphogate'', virtually no CD19 + B-lymphocytes were detected (middle), and strongly reduced CD3 + T-lymphocyte counts were found (right), whereas the NK-cell counts (CD3 ) /CD56 + /CD16 + ) were within the normal range for age (right). (B) Analysis of peripheral blood of a B + X-linked SCID patient with a mutation in the c c gene. This boy presented at the age of 4 months with pneumonia, diarrhoea and sepsis. Dot plot with FSC and SSC shows thè`l ympho-gate'' (left). Within the``lympho-gate'' CD19 + B-lymphocytes were detected (middle), but CD3 + T-lymphocytes were absent (right), and the NK-cell counts (CD3 ) /CD56 + /CD16 + ) were decreased (right)
